Puma Biotechnology
PBYI
PBYI
198 hedge funds and large institutions have $3.55B invested in Puma Biotechnology in 2015 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 72 increasing their positions, 53 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less call options, than puts
Call options by funds: $46.7M | Put options by funds: $47.3M
48% less capital invested
Capital invested by funds: $6.87B → $3.55B (-$3.31B)
86% less funds holding in top 10
Funds holding in top 10: 7 → 1 (-6)
Holders
198
Holding in Top 10
1
Calls
$46.7M
Puts
$47.3M
Top Buyers
| 1 | +$167M | |
| 2 | +$93M | |
| 3 | +$69.1M | |
| 4 |
O
OrbiMed
New York
|
+$66.6M |
| 5 |
CCM
Cornerstone Capital Management
Edina,
Minnesota
|
+$37M |
Top Sellers
| 1 | -$106M | |
| 2 | -$54.2M | |
| 3 | -$52.4M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$49.1M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$46.2M |